Periconceptional use of multivitamins and the occurrence of neural tube defects

J. Mulinare, J. F. Cordero, J. D. Erickson and R. J. Berry
Birth Defects and Genetic Diseases Branch, Centers for Disease Control, Atlanta, Georgia 30333.

We studied the association between multivitamin use during the periconceptional period and the occurrence of neural tube defects using data from the Atlanta Birth Defects Case-Control Study. There were 347 babies with neural tube defects who were live born or stillborn to residents of metropolitan Atlanta from 1968 through 1980. The 2829 control-babies born without birth defects were randomly selected through birth certificates. Periconceptional multivitamin use was defined as reported use for each of the three months before conception through the first three months of pregnancy. Mothers who reported not using multivitamins any time during the six-month period were defined as nonusers. Fourteen percent of mothers reported periconceptional multivitamin use and 40% reported nonuse. Multivitamin users were different from nonusers in a number of demographic, health-related, and life-style characteristics. We found an overall apparent protective effect of periconceptional multivitamin use on the occurrence of neural tube defects, with a crude estimated relative risk of 0.40 (95% confidence interval, 0.25 to 0.63). At this time, it is not possible to determine whether this apparently lower risk is the direct result of multivitamin use or the result of other characteristics of women who use multivitamins.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age
Pietrzik et al.
Am. J. Clin. Nutr. 2007;86:1414-1419.
ABSTRACT | FULL TEXT  

Folate and neural tube defects
Pitkin
Am. J. Clin. Nutr. 2007;85:285S-288S.
ABSTRACT | FULL TEXT  

MicroRNA Responses to Cellular Stress.
Marsit et al.
Cancer Res. 2006;66:10843-10848.
ABSTRACT | FULL TEXT  

Hospitalizations of Newborns With Folate-Sensitive Birth Defects Before and After Fortification of Foods With Folic Acid
Robbins et al.
Pediatrics 2006;118:906-915.
ABSTRACT | FULL TEXT  

Folate and human reproduction
Tamura and Picciano
Am. J. Clin. Nutr. 2006;83:993-1016.
ABSTRACT | FULL TEXT  

Survival of Infants With Neural Tube Defects in the Presence of Folic Acid Fortification
Bol et al.
Pediatrics 2006;117:803-813.
ABSTRACT | FULL TEXT  

Reevaluating the Benefits of Folic Acid Fortification in the United States: Economic Analysis, Regulation, and Public Health
Grosse et al.
Am. J. Public Health 2005;95:1917-1922.
ABSTRACT | FULL TEXT  

Describing a Folic Acid Intervention for Health Care Providers: Implications for Professional Practice and Continuing Education
Helinski et al.
Health Promot Pract 2004;5:326-333.
ABSTRACT  

Management issues for women with epilepsy: Neural tube defects and folic acid supplementation
Yerby
Neurology 2003;61:S23-26.
ABSTRACT | FULL TEXT  

Folic Acid Supplements and Fortification Affect the Risk for Neural Tube Defects, Vascular Disease and Cancer: Evolving Science,
Bailey et al.
J. Nutr. 2003;133:1961S-1968.
ABSTRACT | FULL TEXT  

Folic Acid Intake from Fortification in United States Exceeds Predictions
Choumenkovitch et al.
J. Nutr. 2002;132:2792-2798.
ABSTRACT | FULL TEXT  

DNA Methylation in Folbp1 Knockout Mice Supplemented with Folic Acid during Gestation
Finnell et al.
J. Nutr. 2002;132:2457S-2461.
ABSTRACT | FULL TEXT  

Vitamins for Chronic Disease Prevention in Adults: Scientific Review
Fairfield and Fletcher
JAMA 2002;287:3116-3126.
ABSTRACT | FULL TEXT  

Occurrence of Omphalocele in Relation to Maternal Multivitamin Use: A Population-Based Study
Botto et al.
Pediatrics 2002;109:904-908.
ABSTRACT | FULL TEXT  

Public Health 101 for Informaticians
Koo et al.
J. Am. Med. Inform. Assoc. 2001;8:585-597.
ABSTRACT | FULL TEXT  

Dissecting the ``black box' ' of community intervention: background and rationale
Pearson et al.
Scand J Public Health 2001;29:5-12.
 

Folate, Homocysteine and Neural Tube Defects: An Overview
van der Put et al.
Exp. Biol. Med. 2001;226:243-270.
ABSTRACT | FULL TEXT  

Neural Tube Defects among Mexican Americans Living on the US-Mexico Border: Effects of Folic Acid and Dietary Folate
Suarez et al.
Am J Epidemiol 2000;152:1017-1023.
ABSTRACT | FULL TEXT  

Prevention of Neural Tube Defects by Periconceptional Use of Folic Acid
Iqbal
Pediatr. Rev. 2000;21:58-66.
FULL TEXT  

Prevention of Neural-Tube Defects with Folic Acid in China
Berry et al.
NEJM 1999;341:1485-1490.
ABSTRACT | FULL TEXT  

Neural-Tube Defects
Botto et al.
NEJM 1999;341:1509-1519.
FULL TEXT  

The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
Jacques et al.
NEJM 1999;340:1449-1454.
ABSTRACT | FULL TEXT  

Absorption of Dietary and Supplemental Folate in Women with Prior Pregnancies with Neural Tube Defects and Controls
Neuhouser et al.
J. Am. Coll. Nutr. 1998;17:625-630.
ABSTRACT | FULL TEXT  

Knowledge of Periconceptional Folic Acid for the Prevention of Neural Tube Defects: The Missing Links
Bonin et al.
Arch Fam Med 1998;7:438-442.
ABSTRACT | FULL TEXT  

The folic acid campaign in Wales: changes in women's knowledge from 1995 to 1997
Mckeown et al.
Health Education Journal 1998;57:374-384.
ABSTRACT  

Relation between Maternal Diet and Subsequent Primitive Neuroectodermal Brain Tumors in Young Children
Bunin et al.
NEJM 1993;329:536-541.
ABSTRACT | FULL TEXT  

PRENATAL MULTIVITAMINS MAY DECREASE NEURAL-TUBE DEFECTS
JWatch General 1988;1988:1-1.
FULL TEXT